Thoma Bravo Takes Accelerant Private in $4B+ Insurance Bet Thirteen Months After IPO

Thoma Bravo will take Accelerant private in an all-cash transaction valued at more than $4 billion, barely thirteen months after the insurance marketplace's public debut. The deal marks the largest going-private transaction in the insurance technology sector this year and Thoma Bravo's first pure-play insurance infrastructure acquisition at this scale.

Accelerant operates as a specialty insurance marketplace connecting capacity providers with underwriting teams. The company went public in July 2023 at $20 per share, raising approximately $350 million and achieving a market capitalization near $2.8 billion at debut. Thoma Bravo's offer represents a premium of roughly 43% to that initial listing price, though the company's shares had traded below IPO levels for eight of the past twelve months. The transaction is expected to close in Q4 2024 pending regulatory clearance and shareholder approval.

The timing tells the story. Public markets have systematically undervalued insurance technology platforms that require multi-year buildouts before demonstrating operating leverage. Accelerant's gross written premium grew 67% year-over-year in its most recent quarter, but the company remained unprofitable as it invested in underwriter recruitment and technology infrastructure. Thoma Bravo recognized what public equity analysts missed: specialty insurance capacity is structurally constrained, and digital marketplaces that efficiently allocate that capacity control a toll position worth multiples of current revenue. The firm has deployed more than $8 billion across insurance and financial services software over the past eighteen months, including its $10.5 billion take-private of Zuora in late 2023.

This deal validates two parallel trends. First, the arbitrage between public market impatience and private equity's willingness to fund three-to-five-year infrastructure builds remains wide open. Accelerant's public investors priced quarterly volatility in premium growth; Thoma Bravo prices the terminal value of a scaled marketplace with 15-20% take rates on specialty lines. Second, insurance technology has quietly become a core vertical for software-focused PE. The sector offers recurring revenue models, regulatory moats, and embedded switching costs that software investors understand intimately. Thoma Bravo now controls platform stakes across policy administration, claims processing, and capacity allocation—the three choke points in specialty insurance economics.

Operators and allocators should track three developments through year-end. First, watch whether Thoma Bravo refinances Accelerant's existing debt stack or retires it entirely, which signals their leverage comfort on insurance marketplace cash flows. Second, monitor whether competing PE firms bid for the remaining public insurance technology platforms trading below 1.5x forward revenue, particularly those with embedded capacity or underwriting economics. Third, expect Thoma Bravo to announce at least one bolt-on acquisition for Accelerant within 90-120 days of close, likely a managing general agency or program administrator that brings proprietary underwriting data.

The deal closes the window on insurance marketplace IPOs for the foreseeable future. If a $4 billion private valuation is what it takes to exit a thirteen-month-old listing, the message to pre-IPO insurtech is unambiguous: stay private longer or accept that strategic buyers will pay more than public markets will.